The gastrointestinal microbiome and constituent short-chain fatty acids: a narrative review of an underexplored axis in acute lymphoblastic leukemia.
Gut bacteria-produced compounds may modulate leukemia biology and immunity, highlighting an underexplored therapeutic avenue in blood cancer treatment.
The gut microbiome-SCFA axis is proposed as a novel and underexplored therapeutic dimension in ALL, with mechanistic evidence suggesting SCFAs modulate leukemia cell biology and immune response. A narrative review that frames a relatively unexplored research direction.
What the study was
- Study design
- Narrative review
- Population
- Acute lymphoblastic leukemia (ALL) patients (review context)
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Gut pathogens
Why it surfaced
Gut-ALL microbiome axis is underexplored; narrative review; novel research direction.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.